Search Results - PHARMACOECONOMICS

1

Clinical and pharmacoeconomic profile of COPD patients with FEV1 50—60% predicted: pilot study on the impact of the extended indication of ICS/LABA

by Roberto Walter Dal Negro, Luca Bonadiman, Claudio Turati, Paola Turco
Published 2009-04-01

Get full text

Article

2

Instant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a be...

by Roberto W. Dal Negro, Pietro Longo, Orestepaolo Villanis Ziani, Luca Bonadiman, Paola Turco
Published 2017-06-01

Get full text

Article

3

Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate a...

by Roberto W. Dal Negro, Luca Bonadiman, Paola Turco
Published 2018-07-01

Get full text

Article

4

Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD

by Roberto W. Dal Negro, Paola Turco, Massimiliano Povero
Published 2019-11-01

Get full text

Article

5

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

by Roberto W. Dal Negro, Luca Bonadiman, Paola Turco
Published 2018-06-01

Get full text

Article

6

Patients’ usability of seven most used dry-powder inhalers in COPD

by Roberto W. Dal Negro, Paola Turco, Massimiliano Povero
Published 2019-09-01

Get full text

Article

7

Persistent Cough: Changes in Prevalence, Impact, and Beliefs From 2006–2015 in Italy

by Roberto Walter Dal Negro, Massimiliano Povero, Alessandro Zanasi, Paola Turco
Published 2019-03-01

Get full text

Article

8

Acute cough in Italian children: parents’ beliefs, approach to treatment, and the family impact

by Roberto W. Dal Negro, Alessandro Zanasi, Paola Turco, Massimiliano Povero
Published 2019-04-01

Get full text

Article

9

Influenza and influenza-like syndromes: the subjects’ beliefs, the attitude to prevention and treatment, and the impact in Italian general population

by Roberto W. Dal Negro, Alessandro Zanasi, Paola Turco, Massimiliano Povero
Published 2018-03-01

Get full text

Article

10

The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational study

by Roberto Dal Negro, Luca Bonadiman, Silvia Tognella, Claudio Micheletto, Paola Turco
Published 2011-04-01

“... and pharmacoeconomic terms. Methods: In 2004, the national health authorities stated the appropriateness of long-acting...”

Get full text

Article

Narrow Search